Cargando…

Aura in Cluster Headache: A Cross‐Sectional Study

BACKGROUND: Aura symptoms have been reported in up to 23% of cluster headache patients, but it is not known whether clinical characteristics are different in participants with and without aura. METHODS: Using validated web‐based questionnaires we assessed the presence and characteristics of attack‐r...

Descripción completa

Detalles Bibliográficos
Autores principales:	de Coo, Ilse F., Wilbrink, Leopoldine A., Ie, Gaby D., Haan, Joost, Ferrari, Michel D.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2018
Materias:	Research Submissions
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6220953/ https://www.ncbi.nlm.nih.gov/pubmed/29933513 http://dx.doi.org/10.1111/head.13344

Ejemplares similares

Chronobiology and Sleep in Cluster Headache
por: de Coo, Ilse F., et al.
Publicado: (2019)

Increased use of illicit drugs in a Dutch cluster headache population
por: de Coo, Ilse F, et al.
Publicado: (2018)

Symptomatic Trigeminal Autonomic Cephalalgias
por: de Coo, Ilse F., et al.
Publicado: (2015)

The Neuropsychology of Cluster Headache: Cognition, Mood, Disability, and Quality of Life of Patients With Chronic and Episodic Cluster Headache
por: Torkamani, Mariam, et al.
Publicado: (2015)

Effectiveness of Oxygen and Other Acute Treatments for Cluster Headache: Results From the Cluster Headache Questionnaire, an International Survey
por: Pearson, Stuart M., et al.
Publicado: (2019)

Cluster headache is one of the most intensely painful human conditions: Results from the International Cluster Headache Questionnaire
por: Burish, Mark J., et al.
Publicado: (2020)

Analysis of HCRTR2 Gene Variants and Cluster Headache in Sweden
por: Fourier, Carmen, et al.
Publicado: (2019)

Enlarging the spectrum of cluster headache: Extracranial autonomic involvement revealed by voice analysis
por: Silvestro, Marcello, et al.
Publicado: (2021)

Screening of Two ADH4 Variations in a Swedish Cluster Headache Case–Control Material
por: Fourier, Carmen, et al.
Publicado: (2016)

Tolerability and safety of galcanezumab in patients with chronic cluster headache with up to 15 months of galcanezumab treatment
por: Láinez, Miguel J. A., et al.
Publicado: (2021)

Clinical Characteristics and Treatment Patterns Among Patients Diagnosed With Cluster Headache in U.S. Healthcare Claims Data
por: Choong, Casey K., et al.
Publicado: (2017)

The effect of needle size on cerebrospinal fluid collection time and post‐dural puncture headache: A retrospective cohort study
por: van Dongen, Robin M., et al.
Publicado: (2021)

Cluster headache with aura
por: Martínez-Fernández, Eva, et al.
Publicado: (2002)

Non–Invasive Vagus Nerve Stimulation for the ACute Treatment of Cluster Headache: Findings From the Randomized, Double‐Blind, Sham‐Controlled ACT1 Study
por: Silberstein, Stephen D., et al.
Publicado: (2016)

Preventive migraine treatment with eptinezumab reduced acute headache medication and headache frequency to below diagnostic thresholds in patients with chronic migraine and medication‐overuse headache
por: Marmura, Michael J., et al.
Publicado: (2021)

Long‐Term Outcome of Patients With Intractable Chronic Cluster Headache Treated With Injection of Onabotulinum Toxin A Toward the Sphenopalatine Ganglion – An Observational Study
por: Aschehoug, Irina, et al.
Publicado: (2018)

Treatment Outcomes in Patients Treated With Galcanezumab vs Placebo: Post Hoc Analyses From a Phase 3 Randomized Study in Patients With Episodic Cluster Headache
por: Kudrow, David, et al.
Publicado: (2020)

FORWARD Study: Evaluating the Comparative Effectiveness of OnabotulinumtoxinA and Topiramate for Headache Prevention in Adults With Chronic Migraine
por: Rothrock, John F., et al.
Publicado: (2019)

The teaching of headache medicine in France: A questionnaire‐based study
por: Beltramone, Marion, et al.
Publicado: (2022)

Duration and characteristics of persistent headache following aneurysmal subarachnoid hemorrhage
por: Gaastra, Ben, et al.
Publicado: (2022)

A Randomized Trial to Evaluate OnabotulinumtoxinA for Prevention of Headaches in Adolescents With Chronic Migraine
por: Winner, Paul K., et al.
Publicado: (2020)

Efficacy of ADAM Zolmitriptan for the Acute Treatment of Difficult‐to‐Treat Migraine Headaches
por: Tepper, Stewart J., et al.
Publicado: (2019)

Management of migraine headaches in a chronic pain patient: A case report
por: Bach, Linda Lu, et al.
Publicado: (2016)

Erenumab for headaches in idiopathic intracranial hypertension: A prospective open‐label evaluation
por: Yiangou, Andreas, et al.
Publicado: (2020)

Reduction in the severity and duration of headache following fremanezumab treatment in patients with episodic and chronic migraine
por: Ashina, Messoud, et al.
Publicado: (2021)

Migraine Headache Day Response Rates and the Implications to Patient Functioning: An Evaluation of 3 Randomized Phase 3 Clinical Trials of Galcanezumab in Patients With Migraine
por: Ford, Janet H., et al.
Publicado: (2020)

Characteristics of migraine in patients with headache disorders: A clinic‐based study from Central American and Caribbean countries
por: Monterrey, Priscilla, et al.
Publicado: (2022)

Severe Headache or Migraine History Is Inversely Correlated With Dietary Sodium Intake: NHANES 1999–2004
por: Pogoda, Janice M., et al.
Publicado: (2016)

Comparison and predictors of chronic migraine vs. new daily persistent headache presenting with a chronic migraine phenotype
por: Nagaraj, Karthik, et al.
Publicado: (2022)

Telephone follow‐up on treatment and patient satisfaction at a Danish tertiary headache center: A prospective study
por: Carlsen, Louise Ninett, et al.
Publicado: (2022)

Pharmacotherapy for Cluster Headache
por: Brandt, Roemer B., et al.
Publicado: (2020)

Headache as a COVID‐19 onset symptom and post‐COVID‐19 symptom in hospitalized COVID‐19 survivors infected with the Wuhan, Alpha, or Delta SARS‐CoV‐2 variants
por: Fernández‐de‐las‐Peñas, César, et al.
Publicado: (2022)

Determining Thresholds for Meaningful Change for the Headache Impact Test (HIT‐6) Total and Item‐Specific Scores in Chronic Migraine
por: Houts, Carrie R., et al.
Publicado: (2020)

The Effect of Psychiatric Comorbidities on Headache‐Related Disability in Migraine: Results From the Chronic Migraine Epidemiology and Outcomes (CaMEO) Study
por: Lipton, Richard B., et al.
Publicado: (2020)

A Comparison of the Chronic Migraine Epidemiology and Outcomes (CaMEO) Study and American Migraine Prevalence and Prevention (AMPP) Study: Demographics and Headache‐Related Disability
por: Lipton, Richard B., et al.
Publicado: (2016)

Repeated greater occipital nerve injections with corticosteroids in medically intractable chronic cluster headache: a retrospective study
por: Brandt, Roemer B., et al.
Publicado: (2021)

Combined Photorefractive Keratectomy and Corneal Cross-Linking for Keratoconus and Ectasia: The Athens Protocol
por: Kanellopoulos, Anastasios John
Publicado: (2023)

COVID-19 vaccination-triggered cluster headache episodes with frequent attacks
por: Brandt, Roemer B, et al.
Publicado: (2022)

Migraine aura without headache compared to migraine with aura in patients with affective disorders
por: Oedegaard, K. J., et al.
Publicado: (2005)

Chronic cluster headache: a review
por: Favier, I., et al.
Publicado: (2005)

Cannot write session to /tmp/vufind_sessions/sess_rskkituaepj01hvrutft099fi2